{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T20:39:10Z","timestamp":1787603950881,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.pnpbp.2020.109924","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T06:06:21Z","timestamp":1584079581000},"page":"109924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Predicting the course of anxiety disorders: The role of biological parameters"],"prefix":"10.1016","volume":"101","author":[{"given":"R.C.","family":"Bosman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.L.M.","family":"van Balkom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Rhebergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"van Hemert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Schoevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.W.J.H.","family":"Penninx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.M.","family":"Batelaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2020.109924_bb0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.psyneuen.2014.02.014","article-title":"Prospective associations between the cortisol awakening response and first onsets of anxiety disorders over a six-year follow-up","volume":"44","author":"Adam","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0010","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4088\/JCP.13m08837","article-title":"Two-year course trajectories of anxiety disorders: do DSM classifications matter?","volume":"75","author":"Batelaan","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0015","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1176\/appi.ajp.162.6.1179","article-title":"Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study","volume":"162","author":"Bruce","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0020","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.psyneuen.2010.07.013","article-title":"Determinants of serum brain-derived neurotrophic factor","volume":"36","author":"Bus","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.psyneuen.2013.11.002","article-title":"Depression but not anxiety is associated with metabolic syndrome in primary care based community sample","volume":"40","author":"Butnoriene","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/archpsyc.1981.01780260017001","article-title":"A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility","volume":"38","author":"Carroll","year":"1981","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.biopsych.2009.02.020","article-title":"Generalized anxiety disorder is associated with metabolic syndrome in the Vietnam Experience Study","volume":"66","author":"Carroll","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0040","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.biopsych.2007.05.012","article-title":"A longitudinal typology of symptoms of depression and anxiety over the life course","volume":"62","author":"Colman","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0045","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pnpbp.2007.09.015","article-title":"Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder","volume":"32","author":"Eller","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0050","series-title":"Behavioral Neurobiology of Stress-Related Disorders","first-page":"191","article-title":"Investigation of cortisol levels in patients with anxiety disorders: a structured review","author":"Elnazer","year":"2014"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0055","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/da.22710","article-title":"The bidirectional relationship between anxiety disorders and circulating levels of inflammatory markers: results from a large longitudinal population-based study","volume":"35","author":"Glaus","year":"2018","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0060","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0065","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.psyneuen.2006.10.005","article-title":"Several daily measurements are necessary to reliably assess the cortisol rise after awakening: state- and trait components","volume":"32","author":"Hellhammer","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0070","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/acps.12024","article-title":"Two-year course of anxiety disorders: different across disorders or dimensions?","volume":"128","author":"Hendriks","year":"2013","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2020.109924_bb0075","series-title":"Applied Logistic Regression","author":"Hosmer","year":"2000"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0080","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jad.2015.10.035","article-title":"Low stability of diagnostic classifications of anxiety disorders over time: a six-year follow-up of the NESDA study","volume":"190","author":"Hovenkamp-Hermelink","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2020.109924_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.306","article-title":"Depression, anxiety disorders, and metabolic syndrome in a population at risk for type 2 diabetes mellitus","volume":"5","author":"Kahl","year":"2015","journal-title":"Brain Behav."},{"key":"10.1016\/j.pnpbp.2020.109924_bb0090","first-page":"12","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0095","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11597","article-title":"Inflammation and improvement of depression following electroconvulsive therapy in treatment-resistant depression","volume":"79","author":"Kruse","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.comppsych.2011.01.011","article-title":"Sociodemographic and psychiatric determinants of attrition in the Netherlands Study of Depression and Anxiety (NESDA)","volume":"53","author":"Lamers","year":"2012","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0105","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3109\/15622975.2011.587892","article-title":"Gender specific associations of serum levels of brain-derived neurotrophic factor in anxiety","volume":"13","author":"Molendijk","year":"2012","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/YPG.0000000000000097","article-title":"The met allele of BDNF Val66Met polymorphism is associated with increased BDNF levels in generalized anxiety disorder","volume":"25","author":"Moreira","year":"2015","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2020.109924_bb0115","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.bbi.2010.03.003","article-title":"Clinical anxiety, cortisol and interleukin-6: evidence for specificity in emotion\u2013biology relationships","volume":"24","author":"O\u2019Donovan","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2020.109924_bb0120","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/mp.2015.197","article-title":"Meta-analysis of genome-wide association studies of anxiety disorders","volume":"21","author":"Otowa","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0125","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1177\/0269881113490328","article-title":"Functional topography of serotonergic systems supports the Deakin\/Graeff hypothesis of anxiety and affective disorders","volume":"27","author":"Paul","year":"2013","journal-title":"J. Psychopharmacol. (Oxf.)"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mpr.256","article-title":"The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods","volume":"17","author":"Penninx","year":"2008","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2020.109924_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-11-129","article-title":"Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile","volume":"11","author":"Penninx","year":"2013","journal-title":"BMC Med."},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2020.109924_bb0140","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4","article-title":"Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders","volume":"12","author":"Ressler","year":"2000","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0145","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jad.2012.10.031","article-title":"Recurrence of anxiety disorders and its predictors","volume":"147","author":"Scholten","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2020.109924_bb0150","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.biopsych.2007.01.012","article-title":"Associations between anxiety, depression, and the metabolic syndrome","volume":"62","author":"Skilton","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.janxdis.2016.10.011","article-title":"Prediction of 6-yr symptom course trajectories of anxiety disorders by diagnostic, clinical and psychological variables","volume":"44","author":"Spinhoven","year":"2016","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.pnpbp.2020.109924_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fnint.2013.00055","article-title":"Brain-Derived Neurotrophic Factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis","volume":"7","author":"Suliman","year":"2013","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109924_bb0165","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1600-0047.2004.00328.x","article-title":"12-Month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project","volume":"109","author":"The ESEMeD\/MHEDEA 2000 investigators","year":"2004","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2020.109924_bb0170","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1038\/tp.2013.27","article-title":"Anxiety disorders and inflammation in a large adult cohort","volume":"3","author":"Vogelzangs","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0175","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.psyneuen.2009.04.024","article-title":"Associations between sociodemographic, sampling and health factors and various salivary cortisol indicators in a large sample without psychopathology","volume":"34","author":"Vreeburg","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0180","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/PSY.0b013e3181d2f0c8","article-title":"Salivary cortisol levels in persons with and without different anxiety disorders","volume":"72","author":"Vreeburg","year":"2010","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.pnpbp.2020.109924_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123757","article-title":"Evidence for chronic low-grade systemic inflammation in individuals with agoraphobia from a population-based prospective study","volume":"10","author":"Wagner","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2020.109924_bb0190","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41588-018-0090-3","article-title":"Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression","volume":"50","author":"Wray","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.pnpbp.2020.109924_bb0195","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/da.10106","article-title":"Chronicity, relapse, and illness? Course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up","volume":"17","author":"Yonkers","year":"2003","journal-title":"Depress. Anxiety"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858461931084X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858461931084X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:52:23Z","timestamp":1759521143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027858461931084X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":39,"alternative-id":["S027858461931084X"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2020.109924","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting the course of anxiety disorders: The role of biological parameters","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2020.109924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109924"}}